Drugs / MenACWY-CRM conjugate vaccine, unadjuvanted
last change May 2006 re-read 2 minutes ago

MenACWY-CRM conjugate vaccine, unadjuvanted

Vaccine

Developed for
meningococcal meningitis
Investigated by
Novartis · Novartis Vaccines

Trials 1 · a red edge is where a trial was stopped

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00310817 Mar 2005 → May 2006 meningococcal meningitis Novartis Vaccines Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as MenACWY-CRM conjugate vaccine, unadjuvanted ClinicalTrials.gov intervention name — accepted as the source's own label NCT00310817
Modality Vaccine “MenACWY-CRM conjugate vaccine, unadjuvanted” NCT00310817